data_2hrf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hrf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . 0.265 1.4 m . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 115.322 -2.275 . . . . 0.0 114.854 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.9 t80 84.01 129.55 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.02 2 C-N-CA 137.471 6.309 . . . . 0.0 112.749 -0.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.5 t -67.81 179.7 1.37 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 128.799 2.84 . . . . 0.0 112.205 -3.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -80.12 9.37 47.35 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 125.342 1.448 . . . . 0.0 115.485 -173.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -155.49 138.99 11.02 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.87 1.268 . . . . 0.0 111.244 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.15 129.91 11.71 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.701 2.267 . . . . 0.0 109.858 162.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.97 151.16 22.1 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.508 1.123 . . . . 0.0 108.427 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.4 mp -108.27 168.02 9.6 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.1 0.96 . . . . 0.0 111.035 176.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.42 -61.86 4.56 Favored Glycine 0 N--CA 1.469 0.847 0 C-N-CA 125.409 1.481 . . . . 0.0 111.689 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.27 -162.23 24.24 Favored Glycine 0 CA--C 1.541 1.699 0 C-N-CA 123.958 0.789 . . . . 0.0 114.073 172.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.75 135.81 6.95 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.467 2.778 . . . . 0.0 111.323 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -159.32 169.57 23.73 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.527 1.931 . . . . 0.0 109.602 175.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.4 p -140.24 56.21 1.61 Allowed 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.357 -0.839 . . . . 0.0 113.191 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.35 144.28 53.5 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 119.084 -2.26 . . . . 0.0 111.7 -171.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 62.5 m -98.95 130.03 45.29 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.313 1.445 . . . . 0.0 108.888 -168.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 33.9 p -84.24 158.1 21.37 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 122.666 1.222 . . . . 0.0 111.352 -174.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -62.64 -21.35 65.62 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.83 -1.077 . . . . 0.0 113.295 167.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.8 m -73.56 -12.53 60.79 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.62 1.568 . . . . 0.0 112.31 171.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.41 4.46 64.2 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.405 1.002 . . . . 0.0 114.429 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -88.03 -178.42 5.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.356 1.862 . . . . 0.0 110.921 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -141.04 126.06 18.29 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.16 0.984 . . . . 0.0 110.764 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.01 157.3 26.03 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.731 2.012 . . . . 0.0 113.622 -168.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 31.7 p -132.63 173.53 11.24 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 127.531 2.333 . . . . 0.0 111.495 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.8 -29.24 59.39 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.557 1.543 . . . . 0.0 113.234 172.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.4 mmtm -85.08 -10.02 57.31 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -73.16 -24.57 60.59 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.554 0.615 . . . . 0.0 111.811 160.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 17.8 m-30 -107.39 -73.06 0.7 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.049 1.34 . . . . 0.0 112.817 -167.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.0 tt -66.8 107.9 2.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.6 1.56 . . . . 0.0 108.043 174.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 134.88 -20.68 3.81 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 126.699 2.095 . . . . 0.0 111.941 -162.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -131.26 -170.42 2.37 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.633 1.573 . . . . 0.0 110.557 164.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -97.94 130.38 44.8 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.225 1.01 . . . . 0.0 112.378 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -153.63 154.86 34.99 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.95 126.66 55.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.879 1.672 . . . . 0.0 108.692 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 39.7 mt -115.15 117.58 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.171 0.988 . . . . 0.0 110.534 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -120.04 143.7 47.96 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.917 1.687 . . . . 0.0 112.659 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -98.88 110.7 23.27 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.333 1.053 . . . . 0.0 110.642 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -122.22 -176.29 15.04 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.425 1.488 . . . . 0.0 112.256 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -143.72 132.99 23.16 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.246 1.018 . . . . 0.0 110.476 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.69 37.95 0.19 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.574 1.55 . . . . 0.0 112.539 -175.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -142.62 -16.54 0.71 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -153.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 9.4 m -100.29 161.33 24.46 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.498 1.119 . . . . 0.0 114.011 -163.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -88.93 -17.74 1.98 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.589 2.86 . . . . 0.0 113.091 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -141.78 -71.5 0.34 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -162.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.3 p -61.35 -47.29 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -154.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 85.3 m -56.17 -49.34 74.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.967 0.803 . . . . 0.0 111.308 173.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.93 -44.28 96.49 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.904 1.281 . . . . 0.0 111.261 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.467 ' CD ' ' HZ1' ' A' ' 179' ' ' LYS . 13.5 tm-20 -59.35 -41.92 90.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.742 1.617 . . . . 0.0 111.686 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.94 -41.88 58.76 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 174.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 53.7 mt -63.77 -33.87 76.63 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 117.306 -1.33 . . . . 0.0 112.347 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -56.18 -67.33 0.31 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.864 1.211 . . . . 0.0 109.912 171.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.467 ' HZ1' ' CD ' ' A' ' 175' ' ' GLU . 32.2 mtmm -59.6 -37.21 77.95 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.896 0.878 . . . . 0.0 111.467 -169.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 19.1 tmm? -70.04 -52.6 22.73 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.854 1.262 . . . . 0.0 111.743 176.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 16.4 mm -61.8 -35.47 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-O 117.044 -1.455 . . . . 0.0 112.121 -172.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -49.76 -31.7 12.11 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.879 1.218 . . . . 0.0 112.966 173.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 9.9 t -73.34 -29.45 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.465 0.706 . . . . 0.0 111.862 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 86.6 t -74.46 -48.55 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.144 0.978 . . . . 0.0 109.452 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.79 -35.32 79.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.092 1.357 . . . . 0.0 112.014 174.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -70.26 -44.03 69.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.674 -0.679 . . . . 0.0 112.573 173.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.1 mt -56.29 -43.44 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 119.637 1.108 . . . . 0.0 112.286 177.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.402 ' CG ' ' HZ2' ' A' ' 223' ' ' LYS . 8.9 t0 -69.96 -40.36 75.48 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.941 1.296 . . . . 0.0 111.013 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.6 t -67.36 -47.01 71.67 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.965 0.906 . . . . 0.0 111.642 175.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 19.0 mm -59.33 -24.79 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.278 1.431 . . . . 0.0 111.482 171.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 90.5 m 75.17 -37.7 0.35 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 128.69 2.796 . . . . 0.0 112.518 167.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.4 m -96.05 -9.61 30.5 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.407 2.283 . . . . 0.0 113.574 -159.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.91 162.53 62.02 Favored Pre-proline 0 CA--C 1.546 0.812 0 O-C-N 120.947 -1.096 . . . . 0.0 109.332 163.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -55.57 145.04 71.85 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.192 1.928 . . . . 0.0 109.477 170.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -72.73 146.73 46.23 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 119.73 -0.788 . . . . 0.0 108.953 172.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.5 tp -121.85 128.39 51.59 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.247 0.619 . . . . 0.0 110.86 -165.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 50.3 m -90.51 113.64 58.37 Favored Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 164.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.6 120.55 4.82 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.806 2.338 . . . . 0.0 108.864 160.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.7 tp -115.12 117.45 30.57 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.75 1.22 . . . . 0.0 109.833 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -103.81 125.57 50.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.007 1.323 . . . . 0.0 109.533 175.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 1.6 mp -105.89 133.69 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.198 1.399 . . . . 0.0 109.739 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 21.1 t -85.66 102.26 13.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.528 1.131 . . . . 0.0 111.068 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 11.5 tt -62.91 -15.09 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -163.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -163.54 109.03 0.97 Allowed Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.514 1.125 . . . . 0.0 111.722 174.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.31 64.0 8.4 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.494 2.796 . . . . 0.0 111.828 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -47.19 -34.47 6.37 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 126.77 2.028 . . . . 0.0 113.089 173.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 19.2 ttm105 -174.95 15.26 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 129.027 2.931 . . . . 0.0 110.092 -165.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -73.48 144.16 46.34 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.301 1.04 . . . . 0.0 112.527 -165.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 17.4 m -145.52 133.25 21.07 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.851 0.86 . . . . 0.0 110.144 -153.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -56.91 -34.45 67.96 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -174.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -79.53 -33.54 41.91 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.764 2.026 . . . . 0.0 111.05 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.89 -43.63 74.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.507 0.723 . . . . 0.0 110.907 169.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 16.8 mm -59.02 -44.91 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.643 1.177 . . . . 0.0 111.08 170.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.93 -35.32 74.67 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.908 1.231 . . . . 0.0 112.596 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -69.97 -46.21 65.7 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.717 0.689 . . . . 0.0 112.012 170.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -56.05 -34.44 65.91 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.155 0.982 . . . . 0.0 112.4 172.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 26.1 t -72.45 -44.04 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.009 1.723 . . . . 0.0 112.785 171.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -54.91 -29.41 56.04 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.22 1.808 . . . . 0.0 113.376 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.28 -16.58 59.76 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -171.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -116.2 -69.49 0.85 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 34.2 t -170.71 142.35 1.62 Allowed Pre-proline 0 N--CA 1.476 0.863 0 O-C-N 120.786 -1.196 . . . . 0.0 110.239 -172.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.3 -11.61 30.44 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.137 2.558 . . . . 0.0 114.799 -171.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . 0.402 ' HZ2' ' CG ' ' A' ' 188' ' ' ASP . 71.8 mttt -74.55 -12.32 60.44 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 120.102 1.319 . . . . 0.0 112.763 171.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.8 tp -72.32 95.62 1.75 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 120.843 -1.161 . . . . 0.0 109.638 174.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 4.6 t -81.12 127.34 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.86 113.55 4.73 Favored Glycine 0 N--CA 1.467 0.706 0 C-N-CA 123.902 0.763 . . . . 0.0 111.503 -176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.59 121.38 44.55 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.373 1.069 . . . . 0.0 111.043 -172.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.7 t -125.65 -164.7 1.33 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.804 2.042 . . . . 0.0 108.3 171.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 158.34 -136.67 4.88 Favored Glycine 0 N--CA 1.469 0.841 0 O-C-N 120.26 -1.525 . . . . 0.0 111.706 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.35 154.22 17.59 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.908 0.385 . . . . 0.0 110.717 171.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -34.75 72.36 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.804 -0.56 . . . . 0.0 110.636 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 13.2 mp0 -70.2 -34.52 73.02 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.989 2.115 . . . . 0.0 111.586 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -70.56 -40.44 73.35 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.152 0.981 . . . . 0.0 112.354 169.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.46 -35.56 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 121.488 -0.757 . . . . 0.0 110.906 173.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.25 -50.9 71.81 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.765 1.626 . . . . 0.0 110.631 167.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -52.74 -56.26 16.88 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.002 0.921 . . . . 0.0 109.786 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 47.0 t -66.18 -40.7 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 119.416 1.007 . . . . 0.0 112.859 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -63.14 -34.36 77.45 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.399 -0.813 . . . . 0.0 112.153 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -88.48 -28.22 20.97 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.311 1.444 . . . . 0.0 113.815 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -82.47 -31.11 29.54 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.172 1.351 . . . . 0.0 113.495 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -83.53 -11.76 57.03 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.935 0.789 . . . . 0.0 112.384 157.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 57.54 51.37 9.73 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.269 2.627 . . . . 0.0 114.811 169.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.9 m -73.25 126.34 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 167.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -88.97 63.36 6.71 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.674 1.189 . . . . 0.0 111.514 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -82.09 158.3 23.77 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -174.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 13.0 t -110.54 89.03 8.33 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 123.749 0.819 . . . . 0.0 112.553 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.77 100.06 1.03 Allowed 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.886 2.391 . . . . 0.0 111.405 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.403 ' H ' ' HA ' ' A' ' 258' ' ' VAL . . . -79.44 121.2 5.45 Favored Glycine 0 CA--C 1.54 1.606 0 CA-C-O 117.833 -1.537 . . . . 0.0 111.432 175.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -83.39 176.4 7.3 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 124.483 3.456 . . . . 0.0 113.727 -169.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -91.83 52.54 2.03 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.538 1.535 . . . . 0.0 113.013 -174.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -91.04 6.72 43.72 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -166.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -151.56 -134.11 0.06 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.641 1.576 . . . . 0.0 109.815 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -78.58 63.39 3.38 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 120.519 1.508 . . . . 0.0 114.525 -166.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 69.19 -0.29 2.56 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.244 2.217 . . . . 0.0 115.498 162.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.36 159.82 17.34 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.034 -1.666 . . . . 0.0 112.843 165.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -145.78 60.79 1.26 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.675 1.19 . . . . 0.0 110.747 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 17.8 tt -63.41 57.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 126.75 2.02 . . . . 0.0 114.913 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.403 ' HA ' ' H ' ' A' ' 248' ' ' GLY . 87.4 t -65.95 108.54 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 125.344 1.458 . . . . 0.0 108.167 161.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -58.51 122.18 12.74 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 159.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -109.94 96.43 6.24 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 162.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.2 m -56.9 125.03 20.68 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.156 1.382 . . . . 0.0 110.401 -166.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 17.5 pt -72.93 68.3 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -168.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 60.3 mt -136.64 134.55 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.511 1.524 . . . . 0.0 109.657 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 3.4 ttt -122.12 112.35 18.11 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.661 1.184 . . . . 0.0 110.541 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -83.68 138.42 33.32 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.894 -1.129 . . . . 0.0 112.259 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 7.3 tt -97.28 125.07 41.61 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.887 0.875 . . . . 0.0 109.966 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.0 mp -107.28 138.27 34.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 125.666 1.587 . . . . 0.0 107.666 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.54 167.38 31.09 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.761 169.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -61.02 -27.79 85.19 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.752 2.301 . . . . 0.0 111.198 165.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -73.67 -6.53 47.33 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.599 2.76 . . . . 0.0 113.935 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 131.97 -81.77 0.32 Allowed Glycine 0 C--N 1.345 1.064 0 O-C-N 121.255 -0.903 . . . . 0.0 114.326 171.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -105.1 -142.24 0.37 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -168.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -112.64 115.86 29.25 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 120.64 -1.288 . . . . 0.0 110.297 -150.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -97.66 -12.24 22.62 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.233 0.333 . . . . 0.0 111.847 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -161.55 168.45 23.54 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.949 1.3 . . . . 0.0 113.167 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -151.08 138.92 19.85 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.257 1.823 . . . . 0.0 109.882 165.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -119.19 175.6 5.71 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.297 1.839 . . . . 0.0 111.847 -173.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 160.24 -179.68 35.6 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 129.053 3.216 . . . . 0.0 110.097 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -39.4 -32.02 0.1 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 127.422 2.289 . . . . 0.0 116.423 -172.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -70.23 -43.58 70.34 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -77.87 114.68 16.97 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.497 1.044 . . . . 0.0 110.77 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -76.96 155.7 32.49 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.357 1.063 . . . . 0.0 111.124 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 20.6 tptp -29.37 -63.37 0.12 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.259 2.224 . . . . 0.0 114.974 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.02 -25.52 75.35 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 121.648 -0.658 . . . . 0.0 114.567 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -71.52 -31.44 67.07 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.683 1.241 . . . . 0.0 111.402 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 47.6 mt -64.96 -42.33 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.271 -0.893 . . . . 0.0 109.79 173.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.96 98.23 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.013 0.525 . . . . 0.0 112.166 172.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.23 -37.56 85.87 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.192 0.906 . . . . 0.0 112.839 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.3 -55.93 28.45 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.506 0.722 . . . . 0.0 110.938 166.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 96.0 mt -70.73 -25.27 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 120.517 -1.364 . . . . 0.0 112.303 -173.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.34 -29.36 68.89 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.828 -1.17 . . . . 0.0 112.904 167.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.1 m -70.71 -42.46 70.58 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.781 0.832 . . . . 0.0 109.878 171.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -70.13 -29.85 66.88 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.805 0.842 . . . . 0.0 112.893 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -65.15 -37.96 89.05 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.363 1.865 . . . . 0.0 112.298 166.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -46.52 -45.05 44.82 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 116.78 -1.581 . . . . 0.0 113.557 -172.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.19 -64.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.683 2.255 . . . . 0.0 111.673 163.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -87.75 53.49 2.79 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.518 1.927 . . . . 0.0 113.125 -164.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -67.28 144.07 56.1 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -169.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -54.8 142.77 27.81 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.433 1.493 . . . . 0.0 111.084 158.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.5 128.38 53.54 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 157.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.485 1.285 0 C-N-CA 131.292 3.837 . . . . 0.0 114.87 -12.546 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . 0.265 1.4 m . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 115.322 -2.275 . . . . 0.0 114.854 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.9 t80 84.01 129.55 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.02 2 C-N-CA 137.471 6.309 . . . . 0.0 112.749 -0.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.5 t -67.81 179.7 1.37 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 128.799 2.84 . . . . 0.0 112.205 -3.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -80.12 9.37 47.35 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 125.342 1.448 . . . . 0.0 115.485 -173.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -155.49 138.99 11.02 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.87 1.268 . . . . 0.0 111.244 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.15 129.91 11.71 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.701 2.267 . . . . 0.0 109.858 162.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.97 151.16 22.1 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.508 1.123 . . . . 0.0 108.427 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.4 mp -108.27 168.02 9.6 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.1 0.96 . . . . 0.0 111.035 176.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.42 -61.86 4.56 Favored Glycine 0 N--CA 1.469 0.847 0 C-N-CA 125.409 1.481 . . . . 0.0 111.689 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.27 -162.23 24.24 Favored Glycine 0 CA--C 1.541 1.699 0 C-N-CA 123.958 0.789 . . . . 0.0 114.073 172.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.75 135.81 6.95 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.467 2.778 . . . . 0.0 111.323 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -159.32 169.57 23.73 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.527 1.931 . . . . 0.0 109.602 175.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.4 p -140.24 56.21 1.61 Allowed 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.357 -0.839 . . . . 0.0 113.191 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.35 144.28 53.5 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 119.084 -2.26 . . . . 0.0 111.7 -171.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 62.5 m -98.95 130.03 45.29 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.313 1.445 . . . . 0.0 108.888 -168.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 33.9 p -84.24 158.1 21.37 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 122.666 1.222 . . . . 0.0 111.352 -174.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -62.64 -21.35 65.62 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.83 -1.077 . . . . 0.0 113.295 167.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.8 m -73.56 -12.53 60.79 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.62 1.568 . . . . 0.0 112.31 171.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.41 4.46 64.2 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.405 1.002 . . . . 0.0 114.429 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -88.03 -178.42 5.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.356 1.862 . . . . 0.0 110.921 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -141.04 126.06 18.29 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.16 0.984 . . . . 0.0 110.764 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.01 157.3 26.03 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.731 2.012 . . . . 0.0 113.622 -168.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 31.7 p -132.63 173.53 11.24 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 127.531 2.333 . . . . 0.0 111.495 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.8 -29.24 59.39 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.557 1.543 . . . . 0.0 113.234 172.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.4 mmtm -85.08 -10.02 57.31 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -73.16 -24.57 60.59 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.554 0.615 . . . . 0.0 111.811 160.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 17.8 m-30 -107.39 -73.06 0.7 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.049 1.34 . . . . 0.0 112.817 -167.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.0 tt -66.8 107.9 2.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.6 1.56 . . . . 0.0 108.043 174.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 134.88 -20.68 3.81 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 126.699 2.095 . . . . 0.0 111.941 -162.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -131.26 -170.42 2.37 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.633 1.573 . . . . 0.0 110.557 164.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -97.94 130.38 44.8 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.225 1.01 . . . . 0.0 112.378 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -153.63 154.86 34.99 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.95 126.66 55.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.879 1.672 . . . . 0.0 108.692 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 39.7 mt -115.15 117.58 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.171 0.988 . . . . 0.0 110.534 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -120.04 143.7 47.96 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.917 1.687 . . . . 0.0 112.659 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -98.88 110.7 23.27 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.333 1.053 . . . . 0.0 110.642 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -122.22 -176.29 15.04 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.425 1.488 . . . . 0.0 112.256 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -143.72 132.99 23.16 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.246 1.018 . . . . 0.0 110.476 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.69 37.95 0.19 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.574 1.55 . . . . 0.0 112.539 -175.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -142.62 -16.54 0.71 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -153.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 9.4 m -100.29 161.33 24.46 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.498 1.119 . . . . 0.0 114.011 -163.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -88.93 -17.74 1.98 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.589 2.86 . . . . 0.0 113.091 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -141.78 -71.5 0.34 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -162.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.3 p -61.35 -47.29 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -154.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 85.3 m -56.17 -49.34 74.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.967 0.803 . . . . 0.0 111.308 173.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.93 -44.28 96.49 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.904 1.281 . . . . 0.0 111.261 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.419 ' CD ' ' HZ2' ' A' ' 179' ' ' LYS . 13.5 tm-20 -59.35 -41.92 90.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.742 1.617 . . . . 0.0 111.686 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.94 -41.88 58.76 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 174.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 53.7 mt -63.77 -33.87 76.63 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 117.306 -1.33 . . . . 0.0 112.347 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -56.18 -67.33 0.31 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.864 1.211 . . . . 0.0 109.912 171.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.419 ' HZ2' ' CD ' ' A' ' 175' ' ' GLU . 32.2 mtmm -59.6 -37.21 77.95 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.896 0.878 . . . . 0.0 111.467 -169.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 19.1 tmm? -70.04 -52.6 22.73 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.854 1.262 . . . . 0.0 111.743 176.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 16.4 mm -61.8 -35.47 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-O 117.044 -1.455 . . . . 0.0 112.121 -172.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.476 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 74.2 mt-30 -49.76 -31.7 12.11 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.879 1.218 . . . . 0.0 112.966 173.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 9.9 t -73.34 -29.45 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.465 0.706 . . . . 0.0 111.862 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 86.6 t -74.46 -48.55 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.144 0.978 . . . . 0.0 109.452 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.79 -35.32 79.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.092 1.357 . . . . 0.0 112.014 174.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -70.26 -44.03 69.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.674 -0.679 . . . . 0.0 112.573 173.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.1 mt -56.29 -43.44 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 119.637 1.108 . . . . 0.0 112.286 177.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -69.96 -40.36 75.48 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.941 1.296 . . . . 0.0 111.013 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.6 t -67.36 -47.01 71.67 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.965 0.906 . . . . 0.0 111.642 175.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 19.0 mm -59.33 -24.79 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.278 1.431 . . . . 0.0 111.482 171.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 90.5 m 75.17 -37.7 0.35 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 128.69 2.796 . . . . 0.0 112.518 167.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.4 m -96.05 -9.61 30.5 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.407 2.283 . . . . 0.0 113.574 -159.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.91 162.53 62.02 Favored Pre-proline 0 CA--C 1.546 0.812 0 O-C-N 120.947 -1.096 . . . . 0.0 109.332 163.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -55.57 145.04 71.85 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.192 1.928 . . . . 0.0 109.477 170.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -72.73 146.73 46.23 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 119.73 -0.788 . . . . 0.0 108.953 172.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.5 tp -121.85 128.39 51.59 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.247 0.619 . . . . 0.0 110.86 -165.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 50.3 m -90.51 113.64 58.37 Favored Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 164.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.6 120.55 4.82 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.806 2.338 . . . . 0.0 108.864 160.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.7 tp -115.12 117.45 30.57 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.75 1.22 . . . . 0.0 109.833 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -103.81 125.57 50.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.007 1.323 . . . . 0.0 109.533 175.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 1.6 mp -105.89 133.69 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.198 1.399 . . . . 0.0 109.739 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 21.1 t -85.66 102.26 13.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.528 1.131 . . . . 0.0 111.068 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 11.5 tt -62.91 -15.09 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -163.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -163.54 109.03 0.97 Allowed Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.514 1.125 . . . . 0.0 111.722 174.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.31 64.0 8.4 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.494 2.796 . . . . 0.0 111.828 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -47.19 -34.47 6.37 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 126.77 2.028 . . . . 0.0 113.089 173.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 19.2 ttm105 -174.95 15.26 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 129.027 2.931 . . . . 0.0 110.092 -165.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -73.48 144.16 46.34 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.301 1.04 . . . . 0.0 112.527 -165.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 17.4 m -145.52 133.25 21.07 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.851 0.86 . . . . 0.0 110.144 -153.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -56.91 -34.45 67.96 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -174.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -79.53 -33.54 41.91 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.764 2.026 . . . . 0.0 111.05 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.89 -43.63 74.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.507 0.723 . . . . 0.0 110.907 169.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 16.8 mm -59.02 -44.91 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.643 1.177 . . . . 0.0 111.08 170.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.93 -35.32 74.67 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.908 1.231 . . . . 0.0 112.596 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -69.97 -46.21 65.7 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.717 0.689 . . . . 0.0 112.012 170.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -56.05 -34.44 65.91 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.155 0.982 . . . . 0.0 112.4 172.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 26.1 t -72.45 -44.04 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.009 1.723 . . . . 0.0 112.785 171.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -54.91 -29.41 56.04 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.22 1.808 . . . . 0.0 113.376 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.28 -16.58 59.76 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -171.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -116.2 -69.49 0.85 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 34.2 t -170.71 142.35 1.62 Allowed Pre-proline 0 N--CA 1.476 0.863 0 O-C-N 120.786 -1.196 . . . . 0.0 110.239 -172.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.3 -11.61 30.44 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.137 2.558 . . . . 0.0 114.799 -171.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -74.55 -12.32 60.44 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 120.102 1.319 . . . . 0.0 112.763 171.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.8 tp -72.32 95.62 1.75 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 120.843 -1.161 . . . . 0.0 109.638 174.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 4.6 t -81.12 127.34 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.86 113.55 4.73 Favored Glycine 0 N--CA 1.467 0.706 0 C-N-CA 123.902 0.763 . . . . 0.0 111.503 -176.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.59 121.38 44.55 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.373 1.069 . . . . 0.0 111.043 -172.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.7 t -125.65 -164.7 1.33 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.804 2.042 . . . . 0.0 108.3 171.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 158.34 -136.67 4.88 Favored Glycine 0 N--CA 1.469 0.841 0 O-C-N 120.26 -1.525 . . . . 0.0 111.706 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.35 154.22 17.59 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.908 0.385 . . . . 0.0 110.717 171.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -34.75 72.36 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.804 -0.56 . . . . 0.0 110.636 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.566 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 13.2 mp0 -70.2 -34.52 73.02 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.989 2.115 . . . . 0.0 111.586 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -70.56 -40.44 73.35 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.152 0.981 . . . . 0.0 112.354 169.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.46 -35.56 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 121.488 -0.757 . . . . 0.0 110.906 173.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.25 -50.9 71.81 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.765 1.626 . . . . 0.0 110.631 167.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -52.74 -56.26 16.88 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.002 0.921 . . . . 0.0 109.786 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 47.0 t -66.18 -40.7 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 119.416 1.007 . . . . 0.0 112.859 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -63.14 -34.36 77.45 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.399 -0.813 . . . . 0.0 112.153 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -88.48 -28.22 20.97 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.311 1.444 . . . . 0.0 113.815 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -82.47 -31.11 29.54 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.172 1.351 . . . . 0.0 113.495 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -83.53 -11.76 57.03 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.935 0.789 . . . . 0.0 112.384 157.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 57.54 51.37 9.73 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.269 2.627 . . . . 0.0 114.811 169.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.9 m -73.25 126.34 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 167.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -88.97 63.36 6.71 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.674 1.189 . . . . 0.0 111.514 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -82.09 158.3 23.77 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -174.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 13.0 t -110.54 89.03 8.33 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 123.749 0.819 . . . . 0.0 112.553 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 258' ' ' VAL . 63.9 Cg_endo -71.77 100.06 1.03 Allowed 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.886 2.391 . . . . 0.0 111.405 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -79.44 121.2 5.45 Favored Glycine 0 CA--C 1.54 1.606 0 CA-C-O 117.833 -1.537 . . . . 0.0 111.432 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -83.39 176.4 7.3 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 124.483 3.456 . . . . 0.0 113.727 -169.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -91.83 52.54 2.03 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.538 1.535 . . . . 0.0 113.013 -174.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -91.04 6.72 43.72 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -166.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -151.56 -134.11 0.06 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.641 1.576 . . . . 0.0 109.815 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -78.58 63.39 3.38 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 120.519 1.508 . . . . 0.0 114.525 -166.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 69.19 -0.29 2.56 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.244 2.217 . . . . 0.0 115.498 162.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.36 159.82 17.34 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.034 -1.666 . . . . 0.0 112.843 165.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -145.78 60.79 1.26 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.675 1.19 . . . . 0.0 110.747 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 17.8 tt -63.41 57.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 126.75 2.02 . . . . 0.0 114.913 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 247' ' ' PRO . 87.4 t -65.95 108.54 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 125.344 1.458 . . . . 0.0 108.167 161.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -58.51 122.18 12.74 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 159.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -109.94 96.43 6.24 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 162.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.2 m -56.9 125.03 20.68 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.156 1.382 . . . . 0.0 110.401 -166.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 17.5 pt -72.93 68.3 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -168.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 60.3 mt -136.64 134.55 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.511 1.524 . . . . 0.0 109.657 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 3.4 ttt -122.12 112.35 18.11 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.661 1.184 . . . . 0.0 110.541 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -83.68 138.42 33.32 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.894 -1.129 . . . . 0.0 112.259 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 7.3 tt -97.28 125.07 41.61 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.887 0.875 . . . . 0.0 109.966 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.0 mp -107.28 138.27 34.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 125.666 1.587 . . . . 0.0 107.666 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.54 167.38 31.09 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.761 169.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -61.02 -27.79 85.19 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.752 2.301 . . . . 0.0 111.198 165.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -73.67 -6.53 47.33 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.599 2.76 . . . . 0.0 113.935 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 131.97 -81.77 0.32 Allowed Glycine 0 C--N 1.345 1.064 0 O-C-N 121.255 -0.903 . . . . 0.0 114.326 171.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -105.1 -142.24 0.37 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -168.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -112.64 115.86 29.25 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 120.64 -1.288 . . . . 0.0 110.297 -150.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -97.66 -12.24 22.62 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.233 0.333 . . . . 0.0 111.847 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -161.55 168.45 23.54 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.949 1.3 . . . . 0.0 113.167 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -151.08 138.92 19.85 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.257 1.823 . . . . 0.0 109.882 165.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -119.19 175.6 5.71 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.297 1.839 . . . . 0.0 111.847 -173.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 160.24 -179.68 35.6 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 129.053 3.216 . . . . 0.0 110.097 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -39.4 -32.02 0.1 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 127.422 2.289 . . . . 0.0 116.423 -172.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -70.23 -43.58 70.34 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -77.87 114.68 16.97 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.497 1.044 . . . . 0.0 110.77 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -76.96 155.7 32.49 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.357 1.063 . . . . 0.0 111.124 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.476 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 20.6 tptp -29.37 -63.37 0.12 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.259 2.224 . . . . 0.0 114.974 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.02 -25.52 75.35 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 121.648 -0.658 . . . . 0.0 114.567 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -71.52 -31.44 67.07 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.683 1.241 . . . . 0.0 111.402 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 47.6 mt -64.96 -42.33 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.271 -0.893 . . . . 0.0 109.79 173.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.96 98.23 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.013 0.525 . . . . 0.0 112.166 172.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.23 -37.56 85.87 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.192 0.906 . . . . 0.0 112.839 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.3 -55.93 28.45 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.506 0.722 . . . . 0.0 110.938 166.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 96.0 mt -70.73 -25.27 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 120.517 -1.364 . . . . 0.0 112.303 -173.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.34 -29.36 68.89 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.828 -1.17 . . . . 0.0 112.904 167.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.1 m -70.71 -42.46 70.58 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.781 0.832 . . . . 0.0 109.878 171.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -70.13 -29.85 66.88 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.805 0.842 . . . . 0.0 112.893 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -65.15 -37.96 89.05 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.363 1.865 . . . . 0.0 112.298 166.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -46.52 -45.05 44.82 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 116.78 -1.581 . . . . 0.0 113.557 -172.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.19 -64.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.683 2.255 . . . . 0.0 111.673 163.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -87.75 53.49 2.79 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.518 1.927 . . . . 0.0 113.125 -164.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -67.28 144.07 56.1 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -169.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -54.8 142.77 27.81 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.433 1.493 . . . . 0.0 111.084 158.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.5 128.38 53.54 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 157.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.485 1.285 0 C-N-CA 131.292 3.837 . . . . 0.0 114.87 -12.546 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . 0.265 1.4 m . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 115.322 -2.275 . . . . 0.0 114.854 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.9 t80 84.01 129.55 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.02 2 C-N-CA 137.471 6.309 . . . . 0.0 112.749 -0.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.5 t -67.81 179.7 1.37 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 128.799 2.84 . . . . 0.0 112.205 -3.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -80.12 9.37 47.35 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 125.342 1.448 . . . . 0.0 115.485 -173.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -155.49 138.99 11.02 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.87 1.268 . . . . 0.0 111.244 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.15 129.91 11.71 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.701 2.267 . . . . 0.0 109.858 162.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.97 151.16 22.1 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.508 1.123 . . . . 0.0 108.427 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.4 mp -108.27 168.02 9.6 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.1 0.96 . . . . 0.0 111.035 176.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.42 -61.86 4.56 Favored Glycine 0 N--CA 1.469 0.847 0 C-N-CA 125.409 1.481 . . . . 0.0 111.689 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.27 -162.23 24.24 Favored Glycine 0 CA--C 1.541 1.699 0 C-N-CA 123.958 0.789 . . . . 0.0 114.073 172.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.75 135.81 6.95 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.467 2.778 . . . . 0.0 111.323 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -159.32 169.57 23.73 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.527 1.931 . . . . 0.0 109.602 175.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.4 p -140.24 56.21 1.61 Allowed 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.357 -0.839 . . . . 0.0 113.191 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.35 144.28 53.5 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 119.084 -2.26 . . . . 0.0 111.7 -171.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 62.5 m -98.95 130.03 45.29 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.313 1.445 . . . . 0.0 108.888 -168.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 33.9 p -84.24 158.1 21.37 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 122.666 1.222 . . . . 0.0 111.352 -174.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -62.64 -21.35 65.62 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.83 -1.077 . . . . 0.0 113.295 167.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.8 m -73.56 -12.53 60.79 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.62 1.568 . . . . 0.0 112.31 171.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.41 4.46 64.2 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.405 1.002 . . . . 0.0 114.429 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -88.03 -178.42 5.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.356 1.862 . . . . 0.0 110.921 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -141.04 126.06 18.29 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.16 0.984 . . . . 0.0 110.764 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.01 157.3 26.03 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.731 2.012 . . . . 0.0 113.622 -168.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 31.7 p -132.63 173.53 11.24 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 127.531 2.333 . . . . 0.0 111.495 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.8 -29.24 59.39 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.557 1.543 . . . . 0.0 113.234 172.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.4 mmtm -85.08 -10.02 57.31 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -73.16 -24.57 60.59 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.554 0.615 . . . . 0.0 111.811 160.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 17.8 m-30 -107.39 -73.06 0.7 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.049 1.34 . . . . 0.0 112.817 -167.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.0 tt -66.8 107.9 2.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.6 1.56 . . . . 0.0 108.043 174.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 134.88 -20.68 3.81 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 126.699 2.095 . . . . 0.0 111.941 -162.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -131.26 -170.42 2.37 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.633 1.573 . . . . 0.0 110.557 164.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -97.94 130.38 44.8 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.225 1.01 . . . . 0.0 112.378 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -153.63 154.86 34.99 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.95 126.66 55.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.879 1.672 . . . . 0.0 108.692 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 39.7 mt -115.15 117.58 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.171 0.988 . . . . 0.0 110.534 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -120.04 143.7 47.96 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.917 1.687 . . . . 0.0 112.659 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -98.88 110.7 23.27 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.333 1.053 . . . . 0.0 110.642 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -122.22 -176.29 15.04 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.425 1.488 . . . . 0.0 112.256 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -143.72 132.99 23.16 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.246 1.018 . . . . 0.0 110.476 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.69 37.95 0.19 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.574 1.55 . . . . 0.0 112.539 -175.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -142.62 -16.54 0.71 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -153.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 9.4 m -100.29 161.33 24.46 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.498 1.119 . . . . 0.0 114.011 -163.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -88.93 -17.74 1.98 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.589 2.86 . . . . 0.0 113.091 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -141.78 -71.5 0.34 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -162.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.3 p -61.35 -47.29 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -154.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 85.3 m -56.17 -49.34 74.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.967 0.803 . . . . 0.0 111.308 173.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.93 -44.28 96.49 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.904 1.281 . . . . 0.0 111.261 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.419 ' CD ' ' HZ2' ' A' ' 179' ' ' LYS . 13.5 tm-20 -59.35 -41.92 90.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.742 1.617 . . . . 0.0 111.686 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.94 -41.88 58.76 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 174.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 53.7 mt -63.77 -33.87 76.63 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 117.306 -1.33 . . . . 0.0 112.347 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -56.18 -67.33 0.31 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.864 1.211 . . . . 0.0 109.912 171.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.419 ' HZ2' ' CD ' ' A' ' 175' ' ' GLU . 32.2 mtmm -59.6 -37.21 77.95 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.896 0.878 . . . . 0.0 111.467 -169.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 19.1 tmm? -70.04 -52.6 22.73 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.854 1.262 . . . . 0.0 111.743 176.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 16.4 mm -61.8 -35.47 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-O 117.044 -1.455 . . . . 0.0 112.121 -172.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.476 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 74.2 mt-30 -49.76 -31.7 12.11 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.879 1.218 . . . . 0.0 112.966 173.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 9.9 t -73.34 -29.45 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.465 0.706 . . . . 0.0 111.862 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 86.6 t -74.46 -48.55 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.144 0.978 . . . . 0.0 109.452 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.79 -35.32 79.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.092 1.357 . . . . 0.0 112.014 174.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -70.26 -44.03 69.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.674 -0.679 . . . . 0.0 112.573 173.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.1 mt -56.29 -43.44 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 119.637 1.108 . . . . 0.0 112.286 177.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -69.96 -40.36 75.48 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.941 1.296 . . . . 0.0 111.013 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.6 t -67.36 -47.01 71.67 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.965 0.906 . . . . 0.0 111.642 175.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 19.0 mm -59.33 -24.79 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.278 1.431 . . . . 0.0 111.482 171.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 90.5 m 75.17 -37.7 0.35 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 128.69 2.796 . . . . 0.0 112.518 167.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.4 m -96.05 -9.61 30.5 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.407 2.283 . . . . 0.0 113.574 -159.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.91 162.53 62.02 Favored Pre-proline 0 CA--C 1.546 0.812 0 O-C-N 120.947 -1.096 . . . . 0.0 109.332 163.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -55.57 145.04 71.85 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.192 1.928 . . . . 0.0 109.477 170.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -72.73 146.73 46.23 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 119.73 -0.788 . . . . 0.0 108.953 172.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.5 tp -121.85 128.39 51.59 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.247 0.619 . . . . 0.0 110.86 -165.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 50.3 m -90.51 113.64 58.37 Favored Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 164.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.6 120.55 4.82 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.806 2.338 . . . . 0.0 108.864 160.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.7 tp -115.12 117.45 30.57 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.75 1.22 . . . . 0.0 109.833 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -103.81 125.57 50.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.007 1.323 . . . . 0.0 109.533 175.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 1.6 mp -105.89 133.69 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.198 1.399 . . . . 0.0 109.739 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 21.1 t -85.66 102.26 13.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.528 1.131 . . . . 0.0 111.068 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 11.5 tt -62.91 -15.09 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -163.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -163.54 109.03 0.97 Allowed Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.514 1.125 . . . . 0.0 111.722 174.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.31 64.0 8.4 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.494 2.796 . . . . 0.0 111.828 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -47.19 -34.47 6.37 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 126.77 2.028 . . . . 0.0 113.089 173.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 19.2 ttm105 -174.95 15.26 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 129.027 2.931 . . . . 0.0 110.092 -165.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -73.48 144.16 46.34 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.301 1.04 . . . . 0.0 112.527 -165.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 17.4 m -145.52 133.25 21.07 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.851 0.86 . . . . 0.0 110.144 -153.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -56.91 -34.45 67.96 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -174.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -79.53 -33.54 41.91 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.764 2.026 . . . . 0.0 111.05 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.89 -43.63 74.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.507 0.723 . . . . 0.0 110.907 169.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 16.8 mm -59.02 -44.91 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.643 1.177 . . . . 0.0 111.08 170.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.93 -35.32 74.67 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.908 1.231 . . . . 0.0 112.596 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -69.97 -46.21 65.7 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.717 0.689 . . . . 0.0 112.012 170.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -56.05 -34.44 65.91 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.155 0.982 . . . . 0.0 112.4 172.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 26.1 t -72.45 -44.04 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.009 1.723 . . . . 0.0 112.785 171.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -54.91 -29.41 56.04 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.22 1.808 . . . . 0.0 113.376 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.28 -16.58 59.76 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -171.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -116.2 -69.49 0.85 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 34.2 t -170.71 142.35 1.62 Allowed Pre-proline 0 N--CA 1.476 0.863 0 O-C-N 120.786 -1.196 . . . . 0.0 110.239 -172.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.3 -11.61 30.44 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.137 2.558 . . . . 0.0 114.799 -171.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -74.55 -12.32 60.44 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 120.102 1.319 . . . . 0.0 112.763 171.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.8 tp -72.32 95.62 1.75 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 120.843 -1.161 . . . . 0.0 109.638 174.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 4.6 t -81.12 127.34 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.86 113.55 4.73 Favored Glycine 0 N--CA 1.467 0.706 0 C-N-CA 123.902 0.763 . . . . 0.0 111.503 -176.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.59 121.38 44.55 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.373 1.069 . . . . 0.0 111.043 -172.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.7 t -125.65 -164.7 1.33 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.804 2.042 . . . . 0.0 108.3 171.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 158.34 -136.67 4.88 Favored Glycine 0 N--CA 1.469 0.841 0 O-C-N 120.26 -1.525 . . . . 0.0 111.706 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.35 154.22 17.59 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.908 0.385 . . . . 0.0 110.717 171.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -34.75 72.36 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.804 -0.56 . . . . 0.0 110.636 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.566 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 13.2 mp0 -70.2 -34.52 73.02 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.989 2.115 . . . . 0.0 111.586 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -70.56 -40.44 73.35 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.152 0.981 . . . . 0.0 112.354 169.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.46 -35.56 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 121.488 -0.757 . . . . 0.0 110.906 173.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.25 -50.9 71.81 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.765 1.626 . . . . 0.0 110.631 167.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -52.74 -56.26 16.88 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.002 0.921 . . . . 0.0 109.786 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 47.0 t -66.18 -40.7 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 119.416 1.007 . . . . 0.0 112.859 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -63.14 -34.36 77.45 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.399 -0.813 . . . . 0.0 112.153 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -88.48 -28.22 20.97 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.311 1.444 . . . . 0.0 113.815 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -82.47 -31.11 29.54 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.172 1.351 . . . . 0.0 113.495 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -83.53 -11.76 57.03 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.935 0.789 . . . . 0.0 112.384 157.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 57.54 51.37 9.73 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.269 2.627 . . . . 0.0 114.811 169.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.9 m -73.25 126.34 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 167.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -88.97 63.36 6.71 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.674 1.189 . . . . 0.0 111.514 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -82.09 158.3 23.77 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -174.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 13.0 t -110.54 89.03 8.33 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 123.749 0.819 . . . . 0.0 112.553 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 258' ' ' VAL . 63.9 Cg_endo -71.77 100.06 1.03 Allowed 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.886 2.391 . . . . 0.0 111.405 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -79.44 121.2 5.45 Favored Glycine 0 CA--C 1.54 1.606 0 CA-C-O 117.833 -1.537 . . . . 0.0 111.432 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -83.39 176.4 7.3 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 124.483 3.456 . . . . 0.0 113.727 -169.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -91.83 52.54 2.03 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.538 1.535 . . . . 0.0 113.013 -174.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -91.04 6.72 43.72 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -166.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -151.56 -134.11 0.06 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.641 1.576 . . . . 0.0 109.815 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -78.58 63.39 3.38 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 120.519 1.508 . . . . 0.0 114.525 -166.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 69.19 -0.29 2.56 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.244 2.217 . . . . 0.0 115.498 162.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.36 159.82 17.34 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.034 -1.666 . . . . 0.0 112.843 165.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -145.78 60.79 1.26 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.675 1.19 . . . . 0.0 110.747 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 17.8 tt -63.41 57.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 126.75 2.02 . . . . 0.0 114.913 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 247' ' ' PRO . 87.4 t -65.95 108.54 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 125.344 1.458 . . . . 0.0 108.167 161.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -58.51 122.18 12.74 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 159.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -109.94 96.43 6.24 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 162.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.2 m -56.9 125.03 20.68 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.156 1.382 . . . . 0.0 110.401 -166.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 17.5 pt -72.93 68.3 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -168.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 60.3 mt -136.64 134.55 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.511 1.524 . . . . 0.0 109.657 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 3.4 ttt -122.12 112.35 18.11 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.661 1.184 . . . . 0.0 110.541 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -83.68 138.42 33.32 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.894 -1.129 . . . . 0.0 112.259 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 7.3 tt -97.28 125.07 41.61 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.887 0.875 . . . . 0.0 109.966 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.0 mp -107.28 138.27 34.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 125.666 1.587 . . . . 0.0 107.666 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.54 167.38 31.09 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.761 169.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -61.02 -27.79 85.19 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.752 2.301 . . . . 0.0 111.198 165.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -73.67 -6.53 47.33 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.599 2.76 . . . . 0.0 113.935 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 131.97 -81.77 0.32 Allowed Glycine 0 C--N 1.345 1.064 0 O-C-N 121.255 -0.903 . . . . 0.0 114.326 171.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -105.1 -142.24 0.37 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -168.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -112.64 115.86 29.25 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 120.64 -1.288 . . . . 0.0 110.297 -150.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -97.66 -12.24 22.62 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.233 0.333 . . . . 0.0 111.847 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -161.55 168.45 23.54 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.949 1.3 . . . . 0.0 113.167 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -151.08 138.92 19.85 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.257 1.823 . . . . 0.0 109.882 165.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -119.19 175.6 5.71 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.297 1.839 . . . . 0.0 111.847 -173.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 160.24 -179.68 35.6 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 129.053 3.216 . . . . 0.0 110.097 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -39.4 -32.02 0.1 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 127.422 2.289 . . . . 0.0 116.423 -172.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -70.23 -43.58 70.34 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -77.87 114.68 16.97 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.497 1.044 . . . . 0.0 110.77 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -76.96 155.7 32.49 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.357 1.063 . . . . 0.0 111.124 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.476 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 20.6 tptp -29.37 -63.37 0.12 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.259 2.224 . . . . 0.0 114.974 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.02 -25.52 75.35 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 121.648 -0.658 . . . . 0.0 114.567 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -71.52 -31.44 67.07 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.683 1.241 . . . . 0.0 111.402 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 47.6 mt -64.96 -42.33 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.271 -0.893 . . . . 0.0 109.79 173.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.96 98.23 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.013 0.525 . . . . 0.0 112.166 172.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.23 -37.56 85.87 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.192 0.906 . . . . 0.0 112.839 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.3 -55.93 28.45 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.506 0.722 . . . . 0.0 110.938 166.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 96.0 mt -70.73 -25.27 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 120.517 -1.364 . . . . 0.0 112.303 -173.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.34 -29.36 68.89 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.828 -1.17 . . . . 0.0 112.904 167.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.1 m -70.71 -42.46 70.58 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.781 0.832 . . . . 0.0 109.878 171.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -70.13 -29.85 66.88 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.805 0.842 . . . . 0.0 112.893 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -65.15 -37.96 89.05 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.363 1.865 . . . . 0.0 112.298 166.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -46.52 -45.05 44.82 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 116.78 -1.581 . . . . 0.0 113.557 -172.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.19 -64.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.683 2.255 . . . . 0.0 111.673 163.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -87.75 53.49 2.79 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.518 1.927 . . . . 0.0 113.125 -164.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -67.28 144.07 56.1 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -169.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -54.8 142.77 27.81 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.433 1.493 . . . . 0.0 111.084 158.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.5 128.38 53.54 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 157.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.485 1.285 0 C-N-CA 131.292 3.837 . . . . 0.0 114.87 -12.546 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_